Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 12, 2019

Novartis’ Sandoz to buy Aspen’s Japanese business in $441m deal

Novartis division Sandoz has signed a binding agreement to acquire Aspen Global’s Japanese business in a deal valued at around €400m ($441m).

Continue
Image: Novartis’Sandoz has agreed to buy Aspen’s Japanese business. Photo: courtesy of Novartis.
November 8, 2019

Johnson & Johnson seeks EMA approval for Ebola vaccine regimen

Image: Johnson & Johnson headquarters in New Brunswick, New Jersey. Photo: courtesy of Ekem/Wikipedia.
November 7, 2019

Regeneron, Vyriad sign deal to develop oncolytic virus-based treatments

Image: Regeneron and Vyriad have collaborated to develop oncolytic virus-based treatments. Photo: courtesy of PublicDomainPictures from Pixabay.

Contracts

May 22, 2019

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Image: WuXi Vaccines will build an integrated vaccine manufacturing facility. Photo: courtesy of Arek Socha / Pixabay.

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Deals

Deals November 4, 2019

Amgen enters into strategic collaboration with BeiGene to expand oncology presence in China

Pharmaceutical Business Review

AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m

Takeda acquires TAK-101 license from COUR in $420m deal

Knight Therapeutics to acquire Latin American pharma firm Biotoscana

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

New Data Integrity eLearning From NSF
New Data Integrity eLearning From NSF
New REAL Space Navigator Breaks Billion Compound Barrier
New REAL Space Navigator Breaks Billion Compound Barrier
Bruker Launches Ultrafast FTIR Imaging Microscope LUMOS II
Bruker Launches Ultrafast FTIR Imaging Microscope LUMOS II
Pharmaceutical Business Review
ACTide to Showcase Solutions at CPhI Worldwide 2019
Malvern Panalytical to Host Ore and Minerals Analysis (OMA) Worldwide Workshops
Malvern Panalytical to Host Ore and Minerals Analysis (OMA) Worldwide Workshops

Suppliers

Whitepapers

Saturated Bioisosteres of Benzene
Saturated Bioisosteres of Benzene
Building blocks and linkers for PROTAC synthesis
Building blocks and linkers for PROTAC synthesis
Is Your Outsourcing Project ‘Out Of Mind and Out Of Hand’
Is Your Outsourcing Project ‘Out Of Mind and Out Of Hand’